March 21st, 2019
Sherlock Biosciences licenses Wyss technology to create affordable molecular diagnostics
Synthetic biology-based diagnostic platform enables low-cost, highly sensitive detection of nucleic acids in a wide range of settings
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
March 21st, 2019
Synthetic biology-based diagnostic platform enables low-cost, highly sensitive detection of nucleic acids in a wide range of settings
November 7th, 2018
Harvard researchers' startup, which uses machine learning to design and test chemical compounds, is profiled in Technology Review
August 22nd, 2018
Startup company will initially focus on infants suffering from neonatal abstinence syndrome
May 30th, 2018
Through a new license, Harvard lab’s innovations in genome engineering might solve the organ transplant shortage
May 14th, 2018
Harvard innovations enable the correction of single-base mutations in DNA with unprecedented precision and efficiency